Journey Medical Dividends
| DERM Stock | USD 7.73 0.02 0.26% |
As of the 15th of February 2026, Dividends Paid is likely to drop to about 317.2 K. In addition to that, Dividend Paid And Capex Coverage Ratio is likely to drop to -0.58. Journey Medical's past performance could be the main factor of why investors trade Journey Medical Corp stock today. Investors should clearly understand every aspect of the Journey Medical dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Journey Medical's dividend schedule and payout information. Journey Medical Corp dividends can also provide a clue to the current valuation of Journey Medical.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 333.9 K | 317.2 K | |
| Dividend Paid And Capex Coverage Ratio | (0.55) | (0.58) |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Journey Medical must own a stock before its ex-dividend date to receive its next dividend.
Journey Medical Dividends Paid Over Time
Today, most investors in Journey Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Journey Medical's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's dividends paid growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Journey Medical dividends paid as a starting point in their analysis.
The total amount of dividends that a company has paid out to its shareholders over a specific period. Dividends Paid |
| Timeline |
Will Biotechnology sector continue expanding? Could Journey diversify its offerings? Factors like these will boost the valuation of Journey Medical. Projected growth potential of Journey fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Journey Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.35) | Revenue Per Share | Quarterly Revenue Growth 0.205 | Return On Assets | Return On Equity |
Understanding Journey Medical Corp requires distinguishing between market price and book value, where the latter reflects Journey's accounting equity. The concept of intrinsic value - what Journey Medical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Journey Medical's price substantially above or below its fundamental value.
It's important to distinguish between Journey Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Journey Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Journey Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.